Avatrombopag (Doptelet)

From HemOnc.org - A Hematology Oncology Wiki

Revision as of 00:22, 4 December 2018 by Jwarner (talk | contribs)

(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

Jump to navigation Jump to search

Mechanism of action

Thrombopoietin receptor agonist

Diseases for which it is used

History of changes in FDA indication

5/21/2018: FDA approved for thrombocytopenia in adults with chronic liver disease scheduled to undergo a procedure.

Also known as

Code names: E5501, YM477, AKR 501
Brand name: Doptelet

Retrieved from "https://hemonc.org/w/index.php?title=Avatrombopag_(Doptelet)&oldid=32962"